ALZHEIMER'S DISEASE: A SCIENTIFIC ANALYSIS OF CAUSES OF DEVELOPMENT AND TREATMENT POSSIBILITIES
Keywords:
Tau proteini, Neyrodegeneratsiya, Genetik omillar, Neyroinflamatsiya, Kognitiv buzilishAbstract
This article provides a scientific review of Alzheimer's disease and its causes, pathogenesis, and treatment options. The disease is mainly caused by beta-amyloid plaques, pathological aggregation of tau protein, neuroinflammation, and genetic factors. The APOE4, PSEN1, and PSEN2 genes are considered to be the main risk factors for this disease. Preventive measures, including a Mediterranean diet, physical and mental activity, and good sleep hygiene, can help reduce the risk of the disease. In the future, effective treatment strategies based on gene therapy and advanced biotechnological approaches are expected to be developed.
References
Alzheimer's Association. (2024). 2024 Alzheimer’s Disease Facts and Figures. Alzheimer's & Dementia, 20(3), 487-529. https://www.alz.org
Selkoe, D. J., & Hardy, J. (2016). The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Molecular Medicine, 8(6), 595-608. https://doi.org/10.15252/emmm.201606210
Jack, C. R., et al. (2018). NIA-AA research framework: Toward a biological definition of Alzheimer’s disease. Alzheimer's & Dementia, 14(4), 535-562. https://doi.org/10.1016/j.jalz.2018.02.018
De Strooper, B., & Karran, E. (2016). The Cellular Phase of Alzheimer's Disease. Cell, 164(4), 603-615. https://doi.org/10.1016/j.cell.2016.01.002
Cummings, J., et al. (2023). Advances in Alzheimer’s disease drug development: 2023 pipeline update. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 9(1), e12391. https://doi.org/10.1002/trc2.12391
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sadullayev Savlatjon Sur’at o‘g‘li
This work is licensed under a Creative Commons Attribution 4.0 International License.
(+998)90 142-39-38
m.z.abdutolibov@gmail.com
@universal_jurnal
House 189 Kashgar Street, Marhamat district, Andijan region